tk88 bet

Vietnam to get 31 million Pfizer vaccine doses in Q3, Q4

Vietnam is expected to get 31 million COVID-19 vaccine doses developed by US-based firm Pfizer in the third and fourth quarters of 2021, said the Ministry of Health (MoH).
Vietnam to get 31 million Pfizer vaccine doses in Q3, Q4 ảnh 1Vietnam to get 31 million Pfizer vaccine doses in Q3, Q4 . - Illustrative image (Source: VNA)

Hanoi (VNA) – Vietnam is expected to get 31 million COVID-19 vaccine doses developed byUS-based firm Pfizer in the third and fourth quarters of 2021, said the Ministry of Health (MoH).

The MoH and relevant agencies have taken measures to accelerating negotiationstowards signing an agreement on the purchaseof Pfizer vaccine in line with the vaccine supply roadmap discussed andagreed by the two sides.

According to Heath Minister Nguyen Thanh Long, the ministry has coordinatedwith the Government Office, the Ministry of Planning and Investment, and theMinistry of Justice, to consult Cabinet members on the purchase of Pfizervaccine, and prepare for the signing of an agreement with Pfizer to buy 31million doses as soon as possible.

The negotiation process for this agreement has been continuously promoted bythe MoH during the past time, focusing on terms related to liability, payment,reimbursement and risks when implementing the agreement on the principle ofensuring compliance with the law of Vietnam and international law.

In recent times, the MoH has also continuously negotiated with many COVID-19vaccine manufacturers such as Astra Zeneca, Moderna, Gamelaya with the goal ofhaving enough COVID-19 vaccines to serve thelocals.

It is also working with foreign partners on transfer of vaccine production technologiesto Vietnam.

Vietnam began its COVID-19 inoculation drive on March 8, using the AstraZeneca vaccine of the UK. More than one million COVID-19 vaccine shots weregiven to frontline medical workers and members of community-based anti-COVID-19groups in the country as of 4pm on May 18.

Currently, four Vietnamese vaccines are under development, produced by NagogenPharmaceutical Biotechnology JSC, the Institute of Vaccines and MedicalBiologicals (IVAC), Vaccine and Biological Production Company No. 1 (Vabiotech)and the Center for Research and Production of Vaccines and Biologicals(Polyvac)./.
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

ꦗ Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

🌼 Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|